Dr. Saberi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- University of MichiganFellowship, Cardiovascular Disease, 2007 - 2010
- University of MichiganResidency, Internal Medicine, 2003 - 2006
- Wayne State University School of MedicineClass of 2003
Certifications & Licensure
- MI State Medical License 2003 - 2025
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Study of Exercise Training in Hypertrophic Cardiomyopathy Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions with Automated Assessments in Hypertrophic Cardiomyopathy: A Sub-study from VALOR-HCM.Gary Parizher, Alice Haouzi, Wael A Jaber, Anjali Owens, Kathy Wolski
Journal of the American Society of Echocardiography. 2024-12-27 - Association between age or duration of diagnosis in obstructive hypertrophic cardiomyopathy and response to mavacamten treatment: Exploratory analysis of the EXPLORER-...Andrew Wang, Neal K Lakdawala, Theodore P Abraham, Ester Kim Nilles, Daniel M Wojdyla
Journal of Cardiac Failure. 2024-12-07 - Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.Joshua K Meisner, Aaron Renberg, Eric D Smith, Yao-Chang Tsan, Brynn Elder
Circulation. 2024-12-05
Journal Articles
- Exercise Hemodynamics in Hypertrophic Cardiomyopathy Identify Risk of Incident Heart Failure but Not Ventricular Arrhythmias or Sudden Cardiac Death☆Sharlene M Day, Sara Saberi, International Journal of Cardiology
Press Mentions
- Cytokinetics Presents Positive Results from Cohort 4 of REDWOOD-HCM and Long-Term Results from FOREST-HCM at the American College of Cardiology 72nd Annual Scientific SessionMarch 4th, 2023
- REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health StatusOctober 7th, 2022
- FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic CardiomyopathyMay 6th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: